Related references
Note: Only part of the references are listed.Bone Microarchitecture and Strength in Long-Standing Type 1 Diabetes
Lilian Sewing et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2022)
Greater Carboxy-Methyl-Lysine Is Associated With Increased Fracture Risk in Type 2 Diabetes
Ruban Dhaliwal et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2022)
Biochemical Markers of Bone Turnover in Older Adults With Type 1 Diabetes
Mishaela R. Rubin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)
Risk factors for lower bone mineral density in older adults with type 1 diabetes: a cross-sectional study
Ann Schwartz et al.
LANCET DIABETES & ENDOCRINOLOGY (2022)
Investigation of Mechanical, Material, and Compositional Determinants of Human Trabecular Bone Quality in Type 2 Diabetes
Praveer Sihota et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
The Effects of Type 1 Diabetes and Diabetic Peripheral Neuropathy on the Musculoskeletal System: A Case-Control Study
Tatiane Vilaca et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2021)
Adrenomedullin 2 improves bone regeneration in type 1 diabetic rats by restoring imbalanced macrophage polarization and impaired osteogenesis
Feng Wang et al.
STEM CELL RESEARCH & THERAPY (2021)
Effects of advanced glycation end products on osteocytes mechanosensitivity
Xiao Yang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)
Fracture behavior of human cortical bone: Role of advanced glycation end-products and microstructural features
Ebrahim Maghami et al.
JOURNAL OF BIOMECHANICS (2021)
Comparison of fracture risk between type 1 and type 2 diabetes: a comprehensive real-world data
J. Ha et al.
OSTEOPOROSIS INTERNATIONAL (2021)
Evidence of impaired bone quality in men with type 1 diabetes: a cross-sectional study
Unni Syversen et al.
ENDOCRINE CONNECTIONS (2021)
Effects of Advanced Glycation End Products on Differentiation and Function of Osteoblasts and Osteoclasts
So Young Park et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2021)
Increased Risk of Falls, Fall-related Injuries and Fractures in People with Type 1 and Type 2 Diabetes - A Nationwide Cohort Study
Nicklas H. Rasmussen et al.
CURRENT DRUG SAFETY (2021)
The use of microindentation for the study of bone properties in type 1 diabetes mellitus patients
S. Ballesta et al.
OSTEOPOROSIS INTERNATIONAL (2020)
The risk of hip and non-vertebral fractures in type 1 and type 2 diabetes: A systematic review and meta-analysis update
Tatiane Vilaca et al.
BONE (2020)
Intracellular Accumulation of Advanced Glycation End Products Induces Osteoblast Apoptosis Via Endoplasmic Reticulum Stress
Ryusuke Suzuki et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2020)
Skin Autofluorescence, a Noninvasive Biomarker for Advanced Glycation End-Products, Is Associated With Prevalent Vertebral and Major Osteoporotic Fractures: The Rotterdam Study
Komal Waqas et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2020)
Sclerostin Regulation, Microarchitecture, and Advanced Glycation End-Products in the Bone of Elderly Women With Type 2 Diabetes
Alessandra Piccoli et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2020)
Altered Tissue Composition, Microarchitecture, and Mechanical Performance in Cancellous Bone From Men With Type 2 Diabetes Mellitus
Heather B. Hunt et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2019)
Poor Glycemic Control Is Associated With Impaired Bone Accrual in the Year Following a Diagnosis of Type 1 Diabetes
David R. Weber et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Hypoglycaemia and type 1 diabetes are associated with an increased risk of fractures
M. H. Jensen et al.
OSTEOPOROSIS INTERNATIONAL (2019)
Risk factors for fragility fractures in type 1 diabetes
Giulia Leanza et al.
BONE (2019)
Glycolaldehyde-modified advanced glycation end-products inhibit differentiation of human monocytes into osteoclasts via upregulation of IL-10
Kenichi Tanaka et al.
BONE (2019)
FOXO1 Mediates Advanced Glycation End Products Induced Mouse Osteocyte-Like MLO-Y4 Cell Apoptosis and Dysfunctions
Citong Zhang et al.
JOURNAL OF DIABETES RESEARCH (2019)
Accumulation of carboxymethyl-lysine (CML) in human cortical bone
Corinne J. Thomas et al.
BONE (2018)
Moderate-intensity 4 mT static magnetic fields prevent bone architectural deterioration and strength reduction by stimulating bone formation in streptozotocin-treated diabetic rats
Hao Zhang et al.
BONE (2018)
Bone microarchitecture, biomechanical properties, and advanced glycation end-products in the proximal femur of adults with type 2 diabetes
Lamya Karim et al.
BONE (2018)
Contributions of Material Properties and Structure to Increased Bone Fragility for a Given Bone Mass in the UCD-T2DM Rat Model of Type 2 Diabetes
Claire Acevedo et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2018)
Quadrant Analysis of Quantitative Computed Tomography Scans of the Femoral Neck Reveals Superior Region-Specific Weakness in Young and Middle-Aged Men With Type 1 Diabetes Mellitus
Takuma Kuroda et al.
JOURNAL OF CLINICAL DENSITOMETRY (2018)
Influence of hyperbaric oxygen on biomechanics and structural bone matrix in type 1 diabetes mellitus rats
Pedro Henrique Justino Oliveira Limirio et al.
PLOS ONE (2018)
Advanced glycation end products induced IL-6 and VEGF-A production and apoptosis in osteocyte-like MLO-Y4 cells by activating RAGE and ERK1/2, P38 and STAT3 signalling pathways
Helin Chen et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2017)
Advanced Glycation End Product 3 (AGE3) Increases Apoptosis and the Expression of Sclerostin by Stimulating TGF-β Expression and Secretion in Osteocyte-Like MLO-Y4-A2 Cells
Masakazu Notsu et al.
CALCIFIED TISSUE INTERNATIONAL (2017)
Nonenzymatic Glycation and Degree of Mineralization Are Higher in Bone From Fractured Patients With Type 1 Diabetes Mellitus
Delphine Farlay et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2016)
Diabetes mellitus and risk of hip fractures: a meta-analysis
Y. Fan et al.
OSTEOPOROSIS INTERNATIONAL (2016)
Effect of type 2 diabetes-related non-enzymatic glycation on bone biomechanical properties
Lamya Karim et al.
BONE (2016)
Biochemical bone turnover markers in diabetes mellitus - A systematic review
Jakob Starup-Linde et al.
BONE (2016)
Type 2 Diabetes and Aging: A Not so Sweet Scenario for Bone
R. Dhaliwal et al.
HORMONE AND METABOLIC RESEARCH (2016)
Bone Structure and Predictors of Fracture in Type 1 and Type 2 Diabetes
Jakob Starup-Linde et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Effects of high glucose and advanced glycation end products on the expressions of sclerostin and RANKL as well as apoptosis in osteocyte-like MLO-Y4-A2 cells
Ken-ichiro Tanaka et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Alteration of the bone tissue material properties in type 1 diabetes mellitus: A Fourier transform infrared microspectroscopy study
Aleksandra Mieczkowska et al.
BONE (2015)
Bone Geometry, Volumetric Density, Microarchitecture, and Estimated Bone Strength Assessed by HR-pQCT in Adult Patients With Type 1 Diabetes Mellitus
Vikram V. Shanbhogue et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2015)
Deficits in Trabecular Bone Microarchitecture in Young Women With Type 1 Diabetes Mellitus
Naiemh Abdalrahaman et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2015)
Stable Incretin Mimetics Counter Rapid Deterioration of Bone Quality in Type 1 Diabetes Mellitus
Sity Aishah Mansur et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2015)
A direct role of collagen glycation in bone fracture
Atharva A. Poundarik et al.
JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS (2015)
Clinical and endocrine correlates of circulating sclerostin levels in patients with type 1 diabetes mellitus
Thomas Neumann et al.
CLINICAL ENDOCRINOLOGY (2014)
Circulating Levels of Carboxy-Methyl-Lysine ( CML) Are Associated With Hip Fracture Risk: The Cardiovascular Health Study
Joshua I. Barzilay et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2014)
Biochemical markers of bone turnover in diabetes patients-a meta-analysis, and a methodological study on the effects of glucose on bone markers
J. Starup-Linde et al.
OSTEOPOROSIS INTERNATIONAL (2014)
High serum pentosidine but not esRAGE is associated with prevalent fractures in type 1 diabetes independent of bone mineral density and glycaemic control
T. Neumann et al.
OSTEOPOROSIS INTERNATIONAL (2014)
Advanced glycation end product associated skin autofluorescence: A mirror of vascular function?
Britt Hofmann et al.
EXPERIMENTAL GERONTOLOGY (2013)
Circulating Sclerostin Levels and Bone Turnover in Type 1 and Type 2 Diabetes
Luigi Gennari et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Heterogeneous Glycation of Cancellous Bone and Its Association with Bone Quality and Fragility
Lamya Karim et al.
PLOS ONE (2012)
Increasing duration of type 1 diabetes perturbs the strength-structure relationship and increases brittleness of bone
Jeffry S. Nyman et al.
BONE (2011)
Glycaemic control is positively associated with prevalent fractures but not with bone mineral density in patients with Type 1 diabetes
T. Neumann et al.
DIABETIC MEDICINE (2011)
The relative contributions of non-enzymatic glycation and cortical porosity on the fracture toughness of aging bone
S. Y. Tang et al.
JOURNAL OF BIOMECHANICS (2011)
Type 1 Diabetes in Young Rats Leads to Progressive Trabecular Bone Loss, Cessation of Cortical Bone Growth, and Diminished Whole Bone Strength and Fatigue Life
Matthew J. Silva et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Pentosidine and Increased Fracture Risk in Older Adults with Type 2 Diabetes
Ann V. Schwartz et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Poor glycemic control is associated with low BMD detected in premenopausal women with type 1 diabetes
K. K. Danielson et al.
OSTEOPOROSIS INTERNATIONAL (2009)
Pentosidine effects on human osteoblasts in vitro
Roberta Sanguineti et al.
MAILLARD REACTION: RECENT ADVANCES IN FOOD AND BIOMEDICAL SCIENCES (2008)
An in vitro model to test the contribution of advanced glycation end products to bone biomechanical properties
S. Viguet-Carrin et al.
BONE (2008)
Young women with type 1 diabetes have lower bone mineral density that persists over time
Lucy D. Mastrandrea et al.
DIABETES CARE (2008)
Effects of non-enzymatic glycation on cancellous bone fragility
S. Y. Tang et al.
BONE (2007)
Non-enzymatic glycation of bone collagen modifies osteoclastic activity and differentiation
Ulrich Valcourt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes - a meta-analysis
P. Vestergaard
OSTEOPOROSIS INTERNATIONAL (2007)
Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture
Mohsen Janghorbani et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2007)
Bone density and markers of bone remodeling in type 1 male diabetic patients
O. Alexopoulou et al.
DIABETES & METABOLISM (2006)
Regulation of osteoclast function and bone mass by RAGE
Z Zhou et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Effect of diabetes mellitus on the material properties of the distal tibia
JG Fleischli et al.
JOURNAL OF THE AMERICAN PODIATRIC MEDICAL ASSOCIATION (2006)
The effects of vanadium treatment on bone in diabetic and non-diabetic rats
DM Facchini et al.
BONE (2006)
Elevated hip fracture risk in type 1 diabetic patients
JM Miao et al.
DIABETES CARE (2005)
Trabecular microfracture and the influence of pyridinium and non-enzymatic glycation-mediated collagen cross-links
CJ Hernandez et al.
BONE (2005)
Advanced glycation end-products attenuate human mesenchymal stem cells and prevent cognate differentiation into adipose tissue, cartilage, and bone
S Kume et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
Simple non-invasive assessment of advanced glycation endproduct accumulation
R Meerwaldt et al.
DIABETOLOGIA (2004)
Advanced glycation endproducts interfere with integrin-mediated osteoblastic attachment to a type-I collagen matrix
AD McCarthy et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2004)
Age-related changes in the collagen network and toughness of bone
X Wang et al.
BONE (2002)
Non-enzymatic glycosylation of a type I collagen matrix: effects on osteoblastic development and oxidative stress
AD McCarthy et al.
BMC CELL BIOLOGY (2001)
Share Paper
